Ignite Creation Date:
2024-07-17 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06493461
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-06-28
Brief Title:
A Study of HS135 for the Treatment of Pulmonary Arterial Hypertension in Adults
Sponsor:
35Pharma Inc
Organization:
35Pharma Inc
Study Overview
Official Title:
Phase 1 Multicenter Open-Label Multiple Ascending Dose Study Assessing the Pharmacokinetics Safety Pharmacodynamics and Efficacy of HS135 Added to Background Pulmonary Arterial Hypertension PAH Therapy
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A Study of HS135 for the Treatment of Pulmonary Arterial Hypertension in Adults
Detailed Description:
Phase 1 Multicenter Open-Label Multiple Ascending Dose Study Assessing the Pharmacokinetics Safety Pharmacodynamics and Efficacy of HS135 Added to Background Pulmonary Arterial Hypertension PAH Therapy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None